Athavudh Deesomchok
Overview
Explore the profile of Athavudh Deesomchok including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
432
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liwsrisakun C, Chaiwong W, Deesomchok A, Duangjit P, Pothirat C
Adv Respir Med
. 2025 Feb;
93(1).
PMID: 39996619
Background: Information is limited regarding the role of impulse oscillometry (IOS) for the detection of preserved ratio impaired spirometry (PRISm). Therefore, we aimed to study the diagnostic ability of IOS...
2.
Boontha N, Pirunsan U, Deesomchok A, Chaiwong W, Joseph L, Lin J
Physiother Theory Pract
. 2024 Nov;
:1-13.
PMID: 39570806
Background: The coexistence of pain and chronic obstructive pulmonary disease (COPD) is acknowledged, yet the pain prevalence and associated factors of the common pain area in the COPD population are...
3.
Ngamsutham T, Chaiwong W, Dacha S, Sitilertpisan P, Pothirat C, Duangjit P, et al.
Tuberc Respir Dis (Seoul)
. 2024 Aug;
87(4):532-542.
PMID: 39139078
Background: The sequelae of post-coronavirus disease 2019 (COVID-19) pneumonia on lung function, exercise capacity, and quality of life were observed in both shortterm and long-term. However, the study about the...
4.
Trongtrakul K, Tajarernmuang P, Limsukon A, Theerakittikul T, Niyatiwatchanchai N, Surasit K, et al.
J Clin Med
. 2024 Jan;
13(1).
PMID: 38202305
(1) Background: Early identification of severe coronavirus disease 2019 (COVID-19) pneumonia at the initial phase of hospitalization is very crucial. To address this, we validated and updated the National Early...
5.
Chaiwong W, Deesomchok A, Pothirat C, Duangjit P, Liwsrisakun C
Respir Med
. 2023 Nov;
220:107460.
PMID: 37949150
Background: The impact of the new 2021 European Respiratory Society (ERS)/American Thoracic Society (ATS) pulmonary function test interpretation guidelines on the interpretation of bronchodilator responsiveness (BDR) in subjects with airway...
6.
Chaiwong W, Deesomchok A, Pothirat C, Liwsrisakun C, Duangjit P, Bumroongkit C, et al.
J Thorac Dis
. 2023 Oct;
15(9):4725-4735.
PMID: 37868845
Background: The sequelae of post-coronavirus disease 2019 (COVID-19) have been widely reported. However, the time point of the follow-up time in the previous studies varied ranging from 3-24 months and...
7.
Chaiwong W, Takheaw N, Pata S, Laopajon W, Duangjit P, Inchai J, et al.
Vaccine
. 2023 Aug;
41(40):5901-5909.
PMID: 37599143
Background: Data on humoral and cellular immune responses against SARS-CoV-2 after receiving heterologous CoronaVac/ChAdOx-1 (CoVac/ChAd) vaccination in subjects with chronic obstructive pulmonary disease (COPD) are still limited. Therefore, we determined...
8.
Deesomchok A, Liwsrisakun C, Chaiwong W, Pothirat C, Duangjit P, Bumroongkit C, et al.
Healthcare (Basel)
. 2023 Jul;
11(13).
PMID: 37444797
Many studies have demonstrated poor quality of life (QoL) at 3, 6, 12, and 24 months after coronavirus disease 2019 (COVID-19). However, these studies were limited due to cross-sectional design,...
9.
Takheaw N, Liwsrisakun C, Laopajon W, Pata S, Chaiwong W, Inchai J, et al.
Heliyon
. 2023 Apr;
9(4):e15653.
PMID: 37095993
The outbreak of the SARS-CoV-2 Omicron variant raised the need for vaccine boosting. We evaluated the efficiency of the third booster vaccine, ChAdOx-1 or BNT162b2, in causing a neutralizing antibody...
10.
Bumroongkit C, Limsukon A, Liwsrisakun C, Deesomchok A, Pothirat C, Theerakittikul T, et al.
J Atheroscler Thromb
. 2023 Mar;
30(11):1601-1611.
PMID: 36967130
Aim: To date, no studies representing the Southeast Asian population have validated the Pulmonary Embolism Severity Index (PESI) and 2019 European Society of Cardiology (ESC) risk stratification. Therefore, this study...